Healthcare utilization in patients with first-time implantable cardioverter defibrillators (data from the WEBCARE study)

E.R. Broers, P. Lodder, V.R.M. Spek, J.W.M.G. Widdershoven, S.S. Pedersen, M. Habibovic*

*Corresponding author for this work

Research output: Contribution to journalArticleScientificpeer-review

1 Downloads (Pure)

Abstract

BackgroundKnowledge of the level of healthcare utilization (HCU) and the predictors of high HCU use in patients with an implantable cardioverter defibrillator (ICD) is lacking. We examined the level of HCU and predictors associated with increased HCU in first‐time ICD patients, using a prospective study design.MethodsICD patients (N = 201) completed a set of questionnaires at baseline and 3, 6, and 12 months after inclusion. A hierarchical multiple linear regression with three models was performed to examine predictors of HCU.ResultsHCU was highest between baseline and 3 months postimplantation and gradually decreased during 12 months follow‐up. During the first year postimplantation, only depression (β = 0.342, P = 0.002) was a significant predictor. Between baseline and 3 months follow‐up, younger age (β = −0.220, P < 0.01), New York Heart Association class III/IV (β = 0.705, P = 0.01), and secondary indication (β = 0.148, P = 0.05) were independent predictors for increased HCU. Between 3 and 6 months follow‐up, younger age (β = −0.151, P = 0.05) and depression (β = 0.370, P < 0.001) predicted increased HCU. Between 6 and 12 months only depression (β = 0.355, P = 0.001) remained a significant predictor. ConclusionsDepression was an important predictor of increased HCU in ICD patients in the first year postimplantation, particularly after 3 months postimplantation. Identifying patients who need additional care and provide this on time might better meet patients’ needs and lower future HCU.
Original languageEnglish
Pages (from-to)439-446
JournalPACE. Pacing and Clinical Electrophysiology
Volume42
Issue number4
DOIs
Publication statusPublished - 2019

Fingerprint

Implantable Defibrillators
Delivery of Health Care
Linear Models

Keywords

  • ANXIETY
  • MANAGEMENT
  • QUALITY
  • depression
  • healthcare utilization
  • implantable cardioverter defibrillator
  • mental health

Cite this

@article{920a987cfc2c4739a08a88b35cc1f30e,
title = "Healthcare utilization in patients with first-time implantable cardioverter defibrillators (data from the WEBCARE study)",
abstract = "BackgroundKnowledge of the level of healthcare utilization (HCU) and the predictors of high HCU use in patients with an implantable cardioverter defibrillator (ICD) is lacking. We examined the level of HCU and predictors associated with increased HCU in first‐time ICD patients, using a prospective study design.MethodsICD patients (N = 201) completed a set of questionnaires at baseline and 3, 6, and 12 months after inclusion. A hierarchical multiple linear regression with three models was performed to examine predictors of HCU.ResultsHCU was highest between baseline and 3 months postimplantation and gradually decreased during 12 months follow‐up. During the first year postimplantation, only depression (β = 0.342, P = 0.002) was a significant predictor. Between baseline and 3 months follow‐up, younger age (β = −0.220, P < 0.01), New York Heart Association class III/IV (β = 0.705, P = 0.01), and secondary indication (β = 0.148, P = 0.05) were independent predictors for increased HCU. Between 3 and 6 months follow‐up, younger age (β = −0.151, P = 0.05) and depression (β = 0.370, P < 0.001) predicted increased HCU. Between 6 and 12 months only depression (β = 0.355, P = 0.001) remained a significant predictor. ConclusionsDepression was an important predictor of increased HCU in ICD patients in the first year postimplantation, particularly after 3 months postimplantation. Identifying patients who need additional care and provide this on time might better meet patients’ needs and lower future HCU.",
keywords = "ANXIETY, MANAGEMENT, QUALITY, depression, healthcare utilization, implantable cardioverter defibrillator, mental health",
author = "E.R. Broers and P. Lodder and V.R.M. Spek and J.W.M.G. Widdershoven and S.S. Pedersen and M. Habibovic",
year = "2019",
doi = "10.1111/pace.13636",
language = "English",
volume = "42",
pages = "439--446",
journal = "PACE. Pacing and Clinical Electrophysiology",
issn = "0147-8389",
publisher = "Wiley-Blackwell",
number = "4",

}

Healthcare utilization in patients with first-time implantable cardioverter defibrillators (data from the WEBCARE study). / Broers, E.R.; Lodder, P.; Spek, V.R.M.; Widdershoven, J.W.M.G.; Pedersen, S.S.; Habibovic, M.

In: PACE. Pacing and Clinical Electrophysiology, Vol. 42, No. 4, 2019, p. 439-446.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Healthcare utilization in patients with first-time implantable cardioverter defibrillators (data from the WEBCARE study)

AU - Broers, E.R.

AU - Lodder, P.

AU - Spek, V.R.M.

AU - Widdershoven, J.W.M.G.

AU - Pedersen, S.S.

AU - Habibovic, M.

PY - 2019

Y1 - 2019

N2 - BackgroundKnowledge of the level of healthcare utilization (HCU) and the predictors of high HCU use in patients with an implantable cardioverter defibrillator (ICD) is lacking. We examined the level of HCU and predictors associated with increased HCU in first‐time ICD patients, using a prospective study design.MethodsICD patients (N = 201) completed a set of questionnaires at baseline and 3, 6, and 12 months after inclusion. A hierarchical multiple linear regression with three models was performed to examine predictors of HCU.ResultsHCU was highest between baseline and 3 months postimplantation and gradually decreased during 12 months follow‐up. During the first year postimplantation, only depression (β = 0.342, P = 0.002) was a significant predictor. Between baseline and 3 months follow‐up, younger age (β = −0.220, P < 0.01), New York Heart Association class III/IV (β = 0.705, P = 0.01), and secondary indication (β = 0.148, P = 0.05) were independent predictors for increased HCU. Between 3 and 6 months follow‐up, younger age (β = −0.151, P = 0.05) and depression (β = 0.370, P < 0.001) predicted increased HCU. Between 6 and 12 months only depression (β = 0.355, P = 0.001) remained a significant predictor. ConclusionsDepression was an important predictor of increased HCU in ICD patients in the first year postimplantation, particularly after 3 months postimplantation. Identifying patients who need additional care and provide this on time might better meet patients’ needs and lower future HCU.

AB - BackgroundKnowledge of the level of healthcare utilization (HCU) and the predictors of high HCU use in patients with an implantable cardioverter defibrillator (ICD) is lacking. We examined the level of HCU and predictors associated with increased HCU in first‐time ICD patients, using a prospective study design.MethodsICD patients (N = 201) completed a set of questionnaires at baseline and 3, 6, and 12 months after inclusion. A hierarchical multiple linear regression with three models was performed to examine predictors of HCU.ResultsHCU was highest between baseline and 3 months postimplantation and gradually decreased during 12 months follow‐up. During the first year postimplantation, only depression (β = 0.342, P = 0.002) was a significant predictor. Between baseline and 3 months follow‐up, younger age (β = −0.220, P < 0.01), New York Heart Association class III/IV (β = 0.705, P = 0.01), and secondary indication (β = 0.148, P = 0.05) were independent predictors for increased HCU. Between 3 and 6 months follow‐up, younger age (β = −0.151, P = 0.05) and depression (β = 0.370, P < 0.001) predicted increased HCU. Between 6 and 12 months only depression (β = 0.355, P = 0.001) remained a significant predictor. ConclusionsDepression was an important predictor of increased HCU in ICD patients in the first year postimplantation, particularly after 3 months postimplantation. Identifying patients who need additional care and provide this on time might better meet patients’ needs and lower future HCU.

KW - ANXIETY

KW - MANAGEMENT

KW - QUALITY

KW - depression

KW - healthcare utilization

KW - implantable cardioverter defibrillator

KW - mental health

U2 - 10.1111/pace.13636

DO - 10.1111/pace.13636

M3 - Article

VL - 42

SP - 439

EP - 446

JO - PACE. Pacing and Clinical Electrophysiology

JF - PACE. Pacing and Clinical Electrophysiology

SN - 0147-8389

IS - 4

ER -